Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 13-03-2026
NAV ₹14.44(R) -1.6% ₹15.08(D) -1.59%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 7.44% -% -% -% -%
Direct 9.18% -% -% -% -%
Nifty Pharma TRI 12.8% 26.24% 14.52% 14.92% 7.65%
SIP (XIRR) Regular -6.46% -% -% -% -%
Direct -4.92% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -

NAV Date: 13-03-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - IDCW Option - Regular Plan 14.43
-0.2300
-1.6000%
quant Healthcare Fund - Growth Option - Regular Plan 14.44
-0.2300
-1.6000%
quant Healthcare Fund - IDCW Option - Direct Plan 15.07
-0.2400
-1.5900%
quant Healthcare Fund - Growth Option - Direct Plan 15.08
-0.2400
-1.5900%

Review Date: 13-03-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.76 2.94
-0.25
-2.34 | 2.41 13 | 14 Poor
3M Return % -4.49 0.72
-2.50
-5.86 | 0.84 12 | 14 Average
6M Return % -7.20 3.11
-4.13
-7.22 | -0.41 13 | 14 Poor
1Y Return % 7.44 12.80
8.88
4.82 | 12.89 10 | 13 Average
1Y SIP Return % -6.46
-1.49
-6.58 | 4.05 12 | 13 Average
Return data last Updated On : March 13, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.64 2.94 -0.15 -2.22 | 2.53 13 | 14 Poor
3M Return % -4.13 0.72 -2.19 -5.70 | 1.19 11 | 14 Average
6M Return % -6.47 3.11 -3.48 -6.75 | 0.40 13 | 14 Poor
1Y Return % 9.18 12.80 10.38 6.15 | 14.22 9 | 13 Average
1Y SIP Return % -4.92 -0.42 -4.99 | 5.57 11 | 12 Poor
Return data last Updated On : March 13, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
13-03-2026 14.4354 15.0754
12-03-2026 14.6698 15.3196
11-03-2026 14.7109 15.3618
10-03-2026 14.7741 15.4271
09-03-2026 14.4371 15.0746
06-03-2026 14.6065 15.2494
05-03-2026 14.6429 15.2868
04-03-2026 14.509 15.1463
02-03-2026 14.7045 15.349
27-02-2026 14.9956 15.6509
26-02-2026 15.2059 15.8697
25-02-2026 15.1279 15.7876
24-02-2026 14.9322 15.5827
23-02-2026 14.9852 15.6373
20-02-2026 14.809 15.4514
19-02-2026 14.8074 15.449
18-02-2026 14.9498 15.597
17-02-2026 14.9318 15.5775
16-02-2026 14.7114 15.3469
13-02-2026 14.694 15.3267

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.